Listed

Celldex Therapeutics, Inc.: Form 10-K for the period ended Dec 31, 2013

Filed with the SEC on Mar 3, 2014 and accepted by EDGAR at Mar 3, 2014, 11:36 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2013-10-01 to 2013-12-31$620.0kus-gaap:Revenues
Revenue12 months2013-01-01 to 2013-12-31$4.1mus-gaap:Revenues
Research and development12 months2013-01-01 to 2013-12-31$67.4mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2013-01-01 to 2013-12-31−$81.4mus-gaap:OperatingIncomeLoss
Interest expense12 months2013-01-01 to 2013-12-31$927.0kus-gaap:InterestExpense
Income tax12 months2013-01-01 to 2013-12-31$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2013-10-01 to 2013-12-31−$22.1mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Net income12 months2013-01-01 to 2013-12-31−$81.5mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Diluted EPS3 months2013-10-01 to 2013-12-31−$0.27us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS12 months2013-01-01 to 2013-12-31−$1.02us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2013-01-01 to 2013-12-31−$67.7mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure12 months2013-01-01 to 2013-12-31$4.2mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2013-12-31$169.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-12-31$305.2mus-gaap:AssetsCurrent
Total assetsAt period end2013-12-31$347.1mus-gaap:Assets
Current liabilitiesAt period end2013-12-31$20.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-12-31$27.3mus-gaap:Liabilities
Shareholders' equityAt period end2013-12-31$319.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001047469-14-001653. Last ingested by Listed: Nov 5, 2026, 19:04 ET. Listed shows no prices and gives no investment advice.